Table 4.
Analysis of Risk Factors Associated with Development of Post-infectious Irritable Bowel Syndrome in Shigella-exposed Group During 10-year Follow-up
| Baseline characteristics | OR (95% CI) |
|---|---|
| Age (yr) | |
| < 40 | 1.00 |
| ≥ 40 | 0.94 (0.89–0.99) |
| Sex | |
| Male | 1.00 |
| Female | 2.00 (0.75–5.54) |
| History of other FBDa | |
| No | 1.00 |
| Yes | 5.10 (1.2–21.1) |
| Duration of diarrhea | |
| No | 1.00 |
| Yes | 1.27 (1.01–1.60) |
| Vomiting | |
| No | 1.00 |
| Yes | 0.58 (0.14–2.39) |
| Fever | |
| No | 1.00 |
| Yes | 1.57 (0.68–3.64) |
a
Functional bowel disorders (FBDs) other than irritable bowel syndrome (IBS), including functional abdominal bloating, functional constipation, functional diarrhea, and unspecified FBDs by Rome II criteria.